Friends of Cancer Research
Public Policy OfficesDistrict of Columbia, United States11-50 Employees
Friends of Cancer Research is a public policy organization based in Washington, DC, that aims to accelerate advances in cancer care to extend and improve patients’ lives. The group focuses on shaping policy through collaborations, scientific evidence, and patient input, with a goal of integrating real-world insights into regulatory and legislative processes. Its work targets stakeholders in the cancer research and policy ecosystem, including researchers, clinicians, policymakers, and patient communities, by addressing gaps in policy that affect the development and accessibility of innovative cancer therapies. As an industry actor, it operates within the public policy landscape surrounding cancer research and translational science, pursuing initiatives that foster faster, more effective ways to bring cutting-edge treatments from discovery to patient care. Based in Washington, DC, the organization is described as a small- to mid-sized team that engages in ongoing initiatives and collaborations, including notable recent appointments to its board. A recent development includes adding prominent figures to its Board of Directors, reflecting its engagement with leadership drawn from scientific and regulatory domains.